Skip to content
Forensic Analysis · Industrial & Scientific Instruments · as of Nov 9, 2026

Revvity, Inc. (RVTY)

A forensic read on Revvity, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

B · Sound & dependable
Forensic grade
Safe
Financial health
3.9
Distress distance
Clean
Earnings quality
2
Forensic signals
3.2%
ROE
3.7%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Revvity, Inc. earns a B (Sound & dependable) forensic quality grade, and its balance-sheet distress test reads 3.9, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

3.0%
FY2025
Return on invested capital. Return on invested capital is 3.0% in the latest fiscal year and steady across FY2023–FY2025, inside a 0.8-point range. After-tax operating profit was $271M in FY2023 and $319M in FY2025, with operating income at 10.9% of revenue in FY2023, 12.6% in FY2024 and 12.5% in FY2025. The capital base behind it came down -12% across FY2023–FY2025, from $11.9B to $10.5B, so this return is struck on a smaller base than it started on.
168% of FCF
FY2025
Shareholder returns. Returned $854M to shareholders (buybacks + dividends) in FY2025 — 168% of free cash flow. That is $344M (68%) more than free cash flow covered, and more than operating cash flow as well. New debt covered part of it: total debt rose $67M over FY2025 — $67M of the $344M. The FY2025 cash-flow statement filed net cash used in investing activities of $17M; net cash used in financing activities of $858M. A payout past free cash flow draws the balance sheet down in every year it continues, which isn't sustainable indefinitely. Counting the $23M of stock-based comp paid out in shares on top of that, the combined claim on free cash flow is 172%.

Key fundamentals

Latest Revenue$2.86B
Revenue Growth YoY+3.7%
Revenue CAGR (2yr)+1.9%
Net Margin8.4%
Free Cash Flow$509.4M
Return on Equity3.2%
Debt / Equity0.44x

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Revvity, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.